Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics

Major depressive disorder (MDD) is associated with a significant burden and costs to the society. As remission of depressive symptoms is achieved in only one-third of the MDD patients after the first antidepressant trial, unsuccessful treatments contribute largely to the observed suffering and socia...

Descripción completa

Detalles Bibliográficos
Autores principales: de Sousa, Rafael T., Zanetti, Marcus V., Brunoni, Andre R., Machado-Vieira, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761633/
https://www.ncbi.nlm.nih.gov/pubmed/26467411
http://dx.doi.org/10.2174/1570159X13666150630173522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761633/
https://www.ncbi.nlm.nih.gov/pubmed/26467411
http://dx.doi.org/10.2174/1570159X13666150630173522

Ejemplares similares